Healthcare ❯ Pharmaceuticals ❯ Drug Development ❯ Clinical Trials

Regulatory Approval

FDA Approves Yeztugo, Twice-Yearly HIV Prevention Injection

High pricing paired with uncertain backing by major HIV funders threatens access in low-income nations

FDA Rejects Aldeyra's Reproxalap NDA for Dry Eye Disease Over Efficacy Issues

FDA Approves First New Schizophrenia Drug in Decades